Literature DB >> 3685072

Discriminative stimulus properties of pentobarbital and progesterone in male and female rats.

R P Heinsbroek1, F van Haaren, F Zantvoord, N E van de Poll.   

Abstract

Intact male and ovariectomized female rats were trained to discriminate 12 mg/kg pentobarbital from physiological saline. Generalization tests with different doses of pentobarbital did not reveal significant sex differences in the pentobarbital generalization gradient. Different doses of progesterone produced a generalization gradient to pentobarbital in ovariectomized females, but not in intact males. The results of the present experiment thus suggests that systemic administration of progesterone produces a "pentobarbital-like" stimulus in ovariectomized female rats, but not in intact males.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3685072     DOI: 10.1016/0091-3057(87)90455-2

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  4 in total

Review 1.  Progestins influence motivation, reward, conditioning, stress, and/or response to drugs of abuse.

Authors:  Cheryl A Frye
Journal:  Pharmacol Biochem Behav       Date:  2006-09-18       Impact factor: 3.533

2.  Trends in drug discrimination research analysed with a cross-indexed bibliography, 1984-1987.

Authors:  I P Stolerman; F Rasul; P J Shine
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Effects of progesterone and testosterone on cocaine self-administration and cocaine discrimination by female rhesus monkeys.

Authors:  Nancy K Mello; Inge M Knudson; Maureen Kelly; Peter A Fivel; Jack H Mendelson
Journal:  Neuropsychopharmacology       Date:  2011-07-27       Impact factor: 7.853

4.  Ethanol-like discriminative stimulus effects of the neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one in female Macaca fascicularis monkeys.

Authors:  K A Grant; A Azarov; C A Bowen; S Mirkis; R H Purdy
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.